🟢 Icecure Medical is trading 10.4% up in pre-market — catalyst remains unconfirmed

Icecure Medical is trading 10.4% higher at $1.91, with no confirmed catalyst identified.

• It closed at $1.73 on September 24, 2026.
• No new company-specific announcement or overnight catalyst was identified for September 25. The latest major disclosure remains September 10’s Chinese regulatory approval for ProSense, which appears stale relative to this move.
• Broader futures are modestly higher, but the market backdrop does not clearly explain the sharp gain; the catalyst remains unconfirmed pending further filings or news.